Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effective cytoplasmic release of siRNA from liposomal carriers by controlling the electrostatic interaction of siRNA with a charge-invertible peptide, in response to cytoplasmic pH
Authors
Keywords
-
Journal
Nanoscale
Volume 8, Issue 20, Pages 10649-10658
Publisher
Royal Society of Chemistry (RSC)
Online
2016-04-22
DOI
10.1039/c5nr08365f
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overcoming the polyethylene glycol dilemma via pathological environment-sensitive change of the surface property of nanoparticles for cellular entry
- (2015) Susumu Hama et al. JOURNAL OF CONTROLLED RELEASE
- The present state of the art in expression, production and characterization of monoclonal antibodies
- (2015) Christopher L. Gaughan MOLECULAR DIVERSITY
- Development and Characterization of siRNA Lipoplexes: Effect of Different Lipids, In Vitro Evaluation in Cancerous Cell Lines and In Vivo Toxicity Study
- (2014) Nirav Khatri et al. AAPS PHARMSCITECH
- pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells
- (2014) Sara Bersani et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Current issues of RNAi therapeutics delivery and development
- (2014) D. Haussecker JOURNAL OF CONTROLLED RELEASE
- Preparation of pH-Responsive Polymer Core-Shell Nanospheres for Delivery of Hydrophobic Antineoplastic Drug Ellipticine
- (2013) Hui Wang et al. MACROMOLECULAR BIOSCIENCE
- The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine
- (2012) Naoyuki Toriyabe et al. BIOMATERIALS
- Development of a novel drug delivery system consisting of an antitumor agent tocopheryl succinate
- (2012) Susumu Hama et al. JOURNAL OF CONTROLLED RELEASE
- Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides
- (2012) R. L. Juliano et al. JOURNAL OF DRUG TARGETING
- The Possible “Proton Sponge ” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH
- (2012) Rikke V Benjaminsen et al. MOLECULAR THERAPY
- Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity
- (2011) Erez Koren et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-Targeting Peptide Conjugated pH-Responsive Micelles as a Potential Drug Carrier for Cancer Therapy
- (2010) Xiang Lan Wu et al. BIOCONJUGATE CHEMISTRY
- Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung
- (2010) Melanie Günther et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
- (2010) Amr S. Abu Lila et al. PHARMACEUTICAL RESEARCH
- Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
- (2009) Shyh-Dar Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Multi-layered nanoparticles for penetrating the endosome and nuclear membrane via a step-wise membrane fusion process
- (2009) Hidetaka Akita et al. BIOMATERIALS
- Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers
- (2009) Patrick Midoux et al. BRITISH JOURNAL OF PHARMACOLOGY
- A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo
- (2009) Hiroto Hatakeyama et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started